Patient Perceptions of Injection Pain and Anxiety: A Comparison of NovoFine 32-Gauge Tip 6mm and Micro Fine Plus 31-Gauge 5mm Needles
Authors:
- 1 February 2009
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 11 (2) , 81-86
Abstract
Background: Injecting insulin may cause pain and anxiety and lead to suboptimal treatment of diabetes mellitus. The aim of this randomized, open-label, crossover study was to compare two types of needle design and diameter in patients with diabetes injecting insulin. Methods: Patients with diabetes injecting insulin twice daily for at least 3 months were included. A NovoFine® (Novo Nordisk, Bagsvërd, Denmark) 32-gauge tip 6mm tapered needle and a Micro Fine Plus® (Nippon Becton Dickinson Co. Ltd., Tokyo, Japan) 31-gauge 5mm standard needle were compared. Patients were randomized to use one needle for 1 week, followed by the alternative needle for another week. Before and after each week patients completed a 14-item questionnaire assessing overall satisfaction and usability of the needles. Each item was scored on a visual analog scale from −100 (worst) to +100 (best). Results: Thirty patients (24 men, six women) took part in this study: 24 with type 2 diabetes and six with latent autoimmune diabetes in adults. The mean ± SD for age was 57.8 ± 7.6 years, for body mass index was 23.0 ± 3.1 kg/m2, for duration of diabetes was 15.6 ± 9.8 years, and for mean glycated hemoglobin was 7.1 ± 1.1%. Patients were more satisfied with the use of NovoFine 32-gauge tip 6mm needles (P < 0.0001), found the needles less frightening (P < 0.05) and less painful (P < 0.01), and caused less frequent bleeding and bruising (P < 0.001) than Micro Fine Plus 31-gauge 5mm needles. Conclusions: These results suggest that the diameter and design of the needle play an important role in reducing injection pain and needle anxiety, which is particularly important for insulin initiation.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of Patient's Preference, Pain Perception, and Usability between Micro Fine plus® 31-Gauge Needle and Microtapered NanoPass® 33-Gauge Needle for Insulin TherapyJournal of Diabetes Science and Technology, 2007
- Contents Vol. 66, 2006Hormone Research in Paediatrics, 2006
- Usability of a Microtapered Needle (TN3305) for Insulin Treatment in Japanese Patients with Diabetes Mellitus: A Comparative Clinical Study with a Standard Thin Wall NeedleDiabetes Technology & Therapeutics, 2006
- Pain following controlled cutaneous insertion of needles with different diametersSomatosensory & Motor Research, 2006
- A multicenter, open-label, randomized, two-period crossovertrial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6 mm needle versus a 29 gauge × 12.7 mm needle in obese patients with diabetes mellitusClinical Therapeutics, 2004
- A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClinical Therapeutics, 2003
- When oral agents fail: practical barriers to starting insulinInternational Journal of Obesity, 2002
- Injection related anxiety in insulin-treated diabetesDiabetes Research and Clinical Practice, 1999
- Pain and mechanical injury of human skin following needle insertionsEuropean journal of pain, 1999
- Experience of pain from insulin injections and needle‐phobia in young patients with IDDMPractical Diabetes International, 1997